Stock Events

Stock Events

Ocean Biomedical 

€0.02
0
-€0.01-39.73% Wednesday 17:03

Statistics

Day High
0.02
Day Low
0.02
52W High
0.04
52W Low
0.02
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q1 2025
Next
-0.22
0.11
0.45
0.78
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8AW0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap19.46B
Moderna is a leader in mRNA technology, directly competing in the biotech space for innovative treatments, similar to Ocean Biomedical's focus on novel therapies.
BioNTech
BNTX
Mkt Cap22.65B
BioNTech competes in the development of new therapies and vaccines, including mRNA technology, overlapping with Ocean Biomedical's research areas.
Pfizer
PFE
Mkt Cap144.37B
Pfizer is a large pharmaceutical company with a broad portfolio that includes innovative treatments and vaccines, competing for market share in the biopharmaceutical field.
Novavax
NVAX
Mkt Cap1.49B
Novavax is involved in the development of vaccines for infectious diseases, competing in the same space as Ocean Biomedical's focus on novel healthcare solutions.
Gilead Sciences
GILD
Mkt Cap160.88B
Gilead Sciences is a biopharmaceutical company that develops and markets treatments for life-threatening diseases, directly competing with Ocean Biomedical's mission.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.2B
Regeneron Pharmaceuticals focuses on developing and commercializing treatments for serious medical conditions, competing in the innovative therapy space.
Vertex Pharmaceuticals
VRTX
Mkt Cap110.9B
Vertex Pharmaceuticals is known for creating novel therapies for treating serious diseases, directly competing with Ocean Biomedical's focus areas.
AMGEN
AMGN
Mkt Cap176.21B
Amgen is a biotech firm that develops innovative human therapeutics, competing in the same space as Ocean Biomedical for breakthrough treatments.
Biogen
BIIB
Mkt Cap28.49B
Biogen focuses on developing therapies for neurological diseases, competing with Ocean Biomedical's approach to addressing unmet medical needs.
Novartis
NVS
Mkt Cap282.55B
Novartis is a global healthcare company that offers a wide range of healthcare products, including innovative medicines that compete with Ocean Biomedical's offerings.

About

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Show more...
CEO
Dr. Inderjote Kathuria M.B.A., M.D.
Employees
7
Country
United States
ISIN
US67644C1045

Listings

MU
DE
8AW0.MU
OTC Link
US
OCEAW
OTC Link
US
OCEA

0 Comments

Share your thoughts

FAQ

What is Ocean Biomedical stock price today?▼
The current price of 8AW0.MU is €0.02 EUR — it has decreased by -39.73% in the past 24 hours. Watch Ocean Biomedical stock price performance more closely on the chart.
What is Ocean Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ocean Biomedical stocks are traded under the ticker 8AW0.MU.
When is the next Ocean Biomedical earnings date?▼
Ocean Biomedical is going to release the next earnings report on June 03, 2026.
How many employees does Ocean Biomedical have?▼
As of May 20, 2026, the company has 7 employees.
In which sector is Ocean Biomedical located?▼
Ocean Biomedical operates in the Health & Wellness sector.
When did Ocean Biomedical complete a stock split?▼
Ocean Biomedical has not had any recent stock splits.
Where is Ocean Biomedical headquartered?▼
Ocean Biomedical is headquartered in Providence, United States.